我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

人血浆脂联素分离纯化及活性鉴定

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第2期
页码:
209-213
栏目:
基础研究
出版日期:
2010-12-10

文章信息/Info

Title:
Isolation and purification of adiponectin multimers from human plasma and detection of their bioactivity
作者:
廉坤王海昌王汝涛靳温孙璐马新亮陶凌
第四军医大学西京医院心血管内科,陕西 西安 710032
Author(s):
LIAN Kun WANG Hai-chang WANG Ru-tao JIN Wen SUN Lu MA Xin-liang TAO Ling
Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China
关键词:
脂联素分离纯化活性鉴定
Keywords:
adiponectin isolation purification bioactivity
分类号:
R329.24
DOI:
-
文献标识码:
A
摘要:
目的: 从人血浆中分离纯化各亚型脂联素(APN),建立人血浆APN活性的检测方法,同时获得制备抗APN各亚型特异性抗体所需的抗原。方法:将-80℃保存的人血浆融解后稀释,采用硫酸铵沉淀、阴离子交换层析和凝胶过滤层析分离纯化人血浆中不同亚型的APN。用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、免疫印迹(Western blot)和ELISA检测纯化的产物及回收率。通过孵育人脐静脉内皮细胞后,检测磷酸腺苷激活的蛋白激酶(AMPK)的水平反映APN的活性。结果:所获不同亚型的APN均具有生物学活性,高聚体APN激活AMPK的能力最强。APN活性回收率为40%。结论: 建立了一种能够快速、简便从人血浆中分离纯化APN及其亚型并保持其天然的生物学活性的方法,为APN的深入研究奠定了基础。
Abstract:
AIM: To isolate adiponectin isoforms from human plasma, establish a method to detect human plasma adiponectin isoform biological activity and provide antigen to prepare adiponectin isoform-specific antibody. METHODS: Human plasma stored at -80℃ was thawed and diluted. Plasma adiponectin multimers were isolated by ammonium sulfate precipitation, anion-exchange chromatography and gel filtration chromatography. Adiponectin purity and recovery rate were detected by polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting and enzyme-linked immunosorbent assay (ELISA). Adiponectin bioactivity was detected by incubating human umbilical vein endothelial cells with purified adiponectin isoform and determining the phosphorylation level of AMP-activated protein kinase. RESULTS: The three adiponectin isoforms isolated from plasma all activated AMPK and the high-molecular-weight form was the most potent. Adiponectin activity recovery rate was about 40%. CONCLUSION: Our method efficiently purifies adiponectin multimers from human plasma and preserves their bioactivity, which establishes the basis for further study on adiponectin.

参考文献/References

[1]Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q. produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45):26746-26749.

[2]Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity[J]. J Biol Chem, 1996, 271(18):10697-10703.

[3]Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity[J]. J Biol Chem, 2004, 279(13):12152-12162.

[4]Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J].Nat Med, 2002, 8(11):1288-1295.

[5]Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation[J]. Proc Natl Acad Sci U S A, 2002, 99(25):16309-16313.

[6]Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells[J]. J Biol Chem, 2003, 278(45):45021-45026.

[7]Kobayashi H, Ouchi N, Kihara S, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin[J]. Circ Res, 2004, 94(4):e27-e31.

[8]Wu X, Mahadev K, Fuchsel L, et al. Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling[J]. Am J Physiol Endocrinol Metab, 2007, 293(6):E1836-E1844.

[9]Rodriguez A, Catalan V, Becerril S, et al. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats[J]. Life Sci, 2008, 83(15-16):540-549.

[10]Deng G, Long Y, Yu YR, et al. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway[J]. Int J Obes (Lond), 2010, 34(1):165-171.

[11]Shibata R, Sato K, Pimentel DR, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms[J]. Nat Med, 2005, 11(10):1096-1103.

[12]Gonon AT, Widegren U, Bulhak A, et al. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide[J]. Cardiovasc Res, 2008, 78(1):116-122.

[13]Tao L, Gao E, Jiao X, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress[J]. Circulation, 2007, 115(11):1408-1416.

[14]Li R, Xu M, Wang X, et al. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance[J]. J Mol Cell Cardiol, 2010, 49(3):508-515.

[15]Hada Y, Yamauchi T, Waki H, et al. Selective purification and characterization of adiponectin multimerspecies from human plasma[J]. Biochem Biophys Res Commun, 2007, 356(2):487-493.

[16]Nakano Y, Shoji A, Arakawa A, et al. Adiponectin does not bind to gelatin - A new and easy way to purify HMW adiponectin from human plasma[J]. J Lipid Res, 2009, 51:210-215.

[17]Tanita T, Miyakoshi H, Nakano Y. Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin.[J]. J Immunol Methods, 2008, 333(1-2):139-146.

[18]Nakano Y, Tajima S, Yoshimi A, et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin[J]. J Lipid Res, 2006, 47(7):1572-1582.

备注/Memo

备注/Memo:
收稿日期:2010-07-05.基金项目:国家高技术研究发展计划(2009AA02Z104) 通讯作者:王海昌,主任医师,主要从事冠心病基础研究Email:wanghc@fmmu.edu.cn 共同通讯作者:陶凌,教授,主要从事冠心病基础研究Email:lingtao2006@gmail.com 作者简介:廉坤,硕士生Email:liankun2008@gmail.com
更新日期/Last Update: 2010-12-10